A fund backed by investment bank Leerink Partners raised $313 million for investments in the health information technology sector. Boston-based Leerink Transformation Partners said its first fund was significantly oversubscribed compared with the $250 million it initially sought to raise. Co-founder Todd Cozzens is a medical device industry veteran and former Sequoia Capital partner; Dr. Jared […]
Funding Roundup
Cogentix backs Vensica Medical and its needle-free drug delivery system
Cogentix Medical (NASDAQ: CGNT) said today that it invested $2 million in privately-held Vensica Medical and its ultrasound-based, needle-free drug delivery device, VensiCare. Israel-based Vensica Medical is developing its VensiCare device as a way to deliver botulinum toxin to treat overactive bladder. The company also has IP for the delivery of oncology agents to the bladder, according to Cogentix. […]
Cardinal Analytx closes $6.1m Series A funding round
New machine learning company Cardinal Analytx closed a $6.1 million Series A financing round to fund the development of its healthcare technology with data science, engineering and clinical capabilities. Investors included Cardinal Partners, Premera Blue Cross and the Stanford-StartX Fund. To reduce the costs associated with health insurance, the company developed a machine learning platform […]
Catalent prices offering to help fund Cook Pharmica acquisition
Catalent today priced an underwritten public offering for 6,395,000 shares of its common stock at $39.10 apiece. The offering will be used to fund, in part, the drug-delivery company’s $950 million purchase of biologics manufacturer, Cook Pharmica. In connection with the offering, Catalent granted underwriters a 30-day option to buy up to an additional 959,250 shares of […]
Bellerophon nabs $23m in private placement
Bellerophon Therapeutics (NSDQ:BLPH) said today that it inked a deal with new and existing investors to raise $23.4 million in a private placement of common stocks and warrants. The financing was led by Puissance Capital Management and Venrock Healthcare Capital Partners, supported by existing investors like New Mountain Capital and Linde North America, the Warren, N.J.-based […]
Engage Therapeutics raises $23m Series A for epilepsy drug-device therapy
Summit, N.J.-based Engage Therapeutics said today that it closed a $23 million Series A round to fund a Phase IIb trial of its lead product, Staccato alprazolam. The round was led by TPG Biotech, Adage Capital Management and Lumira Capital. The drug-device product combines a hand-held inhaler technology, which is FDA-approved, with alprazolam, an FDA-approved benzodiazepine. If […]
Analytics 4 Life lands $25m for AI-backed cardiac imaging tech
Analytics 4 Life said today that it landed $25 million in a Series B financing round. A group of investors, including doctors and medical device experts, contributed to the round. The digital health company’s cardiac imaging tech is designed to help physicians assess the presence of coronary artery disease using signals from the body – […]
Pulse Biosciences raises $30m in private placement
Pulse Biosciences (NSDQ:PLSE) said today that it agreed to sell 2 million of the company’s common stock at $15.02 apiece to investor Robert Duggan in a $30 million private placement. The company plans to use the net proceeds from the private placement for working capital or other general corporate purposes, according to a regulatory filing. Earlier […]
B. Braun drops $2m on Fidmi Medical
Fidmi Medical said today that it raised $2 million from B. Braun for the low-profile enteral feeding device it’s developing. The cash is slated for the completion of clinical trials and commercialization, the Misgav, Israel-based company said. “We believe that Fidmi’s enteral feeding tube will make a real difference to patients and caregivers. The investment by […]
Viseon Spine closes $5m Series A round
New medical device company Viseon Spine closed its $5.0 million Series-A financing to fund product development, regulatory approvals, clinical evaluations and manufacturing and commercialization efforts, the company announced today. HBM-MedFocus, Invus Opportunities Fund and affiliates of Wexford Capital LP led the financing round. “We are very pleased to have the support from our investment partners […]
Aspire Capital to acquire $20m worth of Valeritas stock
Valeritas (NSDQ:VLRX) said today that it inked a deal with Aspire Capital Fund to buy $20 million of Valeritas’ common stock. According to the deal, Aspire Capital is slated to purchase common stock at Valeritas’ request from time to time during a 30-month period at prices based on the market price at the time of each […]